Medical Market Report

Global Artificial Implants Market By Type (Orthopedic Implants, Dental Implants, Cardiac Implants, and Cochlear Implants), By Application (Hospitals, and Clinical Research Institutions), By Region, and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2020-2029

  • 135880
  • 18-Dec
  • PDF/PPT/Word
  • ★ ★ ★ ★ ★
    ★ ★ ★ ★ ★
  • Report Details

    Global Artificial Implants Market is estimated to be valued US$ XX.X million in 2019. The report on Artificial Implants Market provides qualitative as well as quantitative analysis in terms of market dynamics, competition scenarios, opportunity analysis, market growth, etc. for the forecast year up to 2029. The global artificial implants market is segmented on the basis of Type, Application, and geography.

    Europe market was valued at US$ XX.X million in 2018 and is projected to reach US$ XX.X million in 2029, and register a CAGR of X.X% during the forecast period, according to a new Market.us (Prudour Research) study.

    Artificial Implants Market Scope:

    By type, the market is segmented into Orthopedic Implants, Dental Implants, Cardiac Implants, and Cochlear Implants. By Application, the market is divided into Hospitals, and Clinical Research Institutions.
    Based on geography, the market is analyzed across North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. Major players profiled in the report include Abiomed Inc. (USA), Advanced Bionics Corporation (USA), Bicon LLC (USA), Biomet 3i Inc. (USA), Biotronik SE & Co. KG (Germany), Boston Scientific Corporation (USA), Cochlear Limited (Australia), Dentsply Sirona (USA), DePuy Synthes Companies (USA), Exactech Inc. (USA), GS Medical LLC (USA), Institut Straumann AG (Switzerland), Integra Lifesciences Holdings Corporation (USA), Japan Medical Dynamic Marketing Inc. (Japan), MED-EL Medical Electronics (Austria), Medtronic plc (Ireland), Nobel Biocare Services AG (Sweden), RTI Surgical Inc. (USA), Showa Ika Kohgyo Co. Ltd (Japan), and Smith & Nephew Plc (UK).

    Key Market Segments

    Type

    Orthopedic Implants

    Dental Implants

    Cardiac Implants

    Cochlear Implants

    Application

    Hospitals

    Clinical Research Institutions

    Key Market Players included in the report:

    Abiomed Inc. (USA)

    Advanced Bionics Corporation (USA)

    Bicon LLC (USA)

    Biomet 3i Inc. (USA)

    Biotronik SE & Co. KG (Germany)

    Boston Scientific Corporation (USA)

    Cochlear Limited (Australia)

    Dentsply Sirona (USA)

    DePuy Synthes Companies (USA)

    Exactech Inc. (USA)

    GS Medical LLC (USA)

    Institut Straumann AG (Switzerland)

    Integra Lifesciences Holdings Corporation (USA)

    Japan Medical Dynamic Marketing Inc. (Japan)

    MED-EL Medical Electronics (Austria)

    Medtronic plc (Ireland)

    Nobel Biocare Services AG (Sweden)

    RTI Surgical Inc. (USA)

    Showa Ika Kohgyo Co. Ltd (Japan)

    Smith & Nephew Plc (UK)

    Reasons to Get this Report:

    In an insight outlook, this research report has dedicated to several quantities of analysis – industry research (global industry trends) and Artificial Implants Market share analysis of high players, along with company profiles, and which collectively include about the fundamental opinions regarding the market landscape; emerging and high-growth sections of Artificial Implants Market; high-growth regions; and market drivers, restraints, and also market chances.
    The analysis covers Artificial Implants Market and its advancements across different industry verticals as well as regions. It targets estimating the current market size and growth potential of the global Artificial Implants Market across sections such as also Application and representatives.
    Additionally, the analysis also has a comprehensive review of the crucial players on the Artificial Implants Market together side their company profiles, SWOT analysis, latest advancements, and business plans.

    The analysis objectives of the report are:

    To equitably share in-depth info regarding the crucial elements impacting the increase of industry (growth capacity, chances, drivers, and industry-specific challenges and risks).
    To know the Artificial Implants Market by pinpointing its many subsegments.
    To profile the important players and analyze their growth plans.
    To endeavor the amount and value of Artificial Implants sub-markets, depending on key regions (various vital states).
    To analyze Artificial Implants Market concerning growth trends, prospects, and also their participation in the entire sector.
    To examine and study the Artificial Implants Market size (volume & value) from the company, essential regions/countries, products, and Application, background information from 2013 to 2018, and also prediction to 2029.
    Primary worldwide Artificial Implants Market manufacturing companies, to specify, clarify and analyze the product sales amount, value and market share, market rivalry landscape, SWOT analysis and development plans next coming years.
    To examine competitive progress such as expansions, arrangements, new product launches, and acquisitions on the market.

  • Table Of Content 
    1. Artificial Implants Market Introduction
    

    1.1. Definition
    
1.2. Taxonomy
    
1.3. Research Scope2. Executive Summary
    

      2.1. Key Findings by Major Segments
    
  2.2. Top strategies by Major Players3. Global Artificial Implants Market Overview
    

    3.1. Artificial Implants Market Dynamics
    

        3.1.1. Drivers
    
    3.1.2. Opportunities
    
    3.1.3. Restraints
    
    3.1.4. Challenges  3.2. PESTLE Analysis
    
  3.3. Opportunity Map Analysis
    
  3.4. PORTER’S Five Forces Analysis
    
  3.5. Market Competition Scenario Analysis
    
  3.6. Product Life Cycle Analysis
    
  3.7. Opportunity Orbits
    
  3.8. Production Analysis by Region/Company
    
  3.9. Industry chain Analysis
    
  3.10. Marketing Strategy4. Global Artificial Implants Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Type, 2012-2028
    

      4.1. Global Artificial Implants Market Analysis by Type: Introduction
    
  4.2. Market Size and Forecast by Region
    
  4.3. Orthopedic Implants
    

      4.4. Dental Implants
    

      4.5. Cardiac Implants
    

      4.6. Cochlear Implants5. Global Artificial Implants Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Application, 2012-2028
    

      5.1. Global Artificial Implants Market Analysis by Application: Introduction
    
  5.2. Market Size and Forecast by Region
    
  5.3. Hospitals
    

      5.4. Clinical Research Institutions6. Global Artificial Implants Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Region, 2012-2028
    

      6.1. North America
    

        6.1.1. North America Artificial Implants Market: Regional Trend Analysis
    

         6.1.1.1. US
    
     6.1.1.2. Canada
    
     6.1.1.3. Mexico
    

      6.2.1. Europe
    

        6.2.1. Europe Artificial Implants Market: Regional Trend Analysis
    

         6.2.1.1. Germany
    
     6.2.1.2. France
    
     6.2.1.3. UK
    
     6.2.1.4. Russia
    
     6.2.1.5. Italy
    
     6.2.1.6. Spain
    
     6.2.1.7. Rest of Europe
    

      6.3. Asia-Pacific
    

        6.3.1. Asia-Pacific Artificial Implants Market: Regional Trend Analysis
    

         6.3.1.1. China
    
     6.3.1.2. Japan
    
     6.3.1.3. Korea
    
     6.3.1.4. India
    
     6.3.1.5. Rest of Asia-Pacific
    

      6.4. Latin America
    

        6.4.1. Latin America Artificial Implants Market: Regional Trend Analysis
    

         6.4.1.1. Brazil
    
     6.4.1.2. Argentina
    
     6.4.1.3. Rest of Latin America
    

      6.5. Middle East and Africa
    

        6.5.1. Middle East and Africa Artificial Implants Market: Regional Trend Analysis
    

         6.5.1.1. GCC
    
     6.5.1.2. South Africa
    
     6.5.1.3. Israel
    
     6.5.1.4. Rest of MEA
    
7. Global Artificial Implants Market Competitive Landscape, Market Share Analysis, and Company Profiles
    

      7.1. Market Share Analysis
    
  7.2. Company Profiles
    
  7.3. Abiomed#Inc. (USA)
    

        7.3.1. Company Overview
    
    7.3.2. Financial Highlights
    
    7.3.3. Product Portfolio
    
    7.3.4. SWOT Analysis
    
    7.3.5. Key Strategies and Developments  7.4. Advanced Bionics Corporation (USA)
    

        7.4.1. Company Overview
    
    7.4.2. Financial Highlights
    
    7.4.3. Product Portfolio
    
    7.4.4. SWOT Analysis
    
    7.4.5. Key Strategies and Developments  7.5. Bicon#LLC (USA)
    

        7.5.1. Company Overview
    
    7.5.2. Financial Highlights
    
    7.5.3. Product Portfolio
    
    7.5.4. SWOT Analysis
    
    7.5.5. Key Strategies and Developments  7.6. Biomet 3i#Inc. (USA)
    

        7.6.1. Company Overview
    
    7.6.2. Financial Highlights
    
    7.6.3. Product Portfolio
    
    7.6.4. SWOT Analysis
    
    7.6.5. Key Strategies and Developments  7.7. Biotronik SE & Co. KG (Germany)
    

        7.7.1. Company Overview
    
    7.7.2. Financial Highlights
    
    7.7.3. Product Portfolio
    
    7.7.4. SWOT Analysis
    
    7.7.5. Key Strategies and Developments  7.8. Boston Scientific Corporation (USA)
    

        7.8.1. Company Overview
    
    7.8.2. Financial Highlights
    
    7.8.3. Product Portfolio
    
    7.8.4. SWOT Analysis
    
    7.8.5. Key Strategies and Developments  7.9. Cochlear Limited (Australia)
    

        7.9.1. Company Overview
    
    7.9.2. Financial Highlights
    
    7.9.3. Product Portfolio
    
    7.9.4. SWOT Analysis
    
    7.9.5. Key Strategies and Developments  7.10. Dentsply Sirona (USA)
    

        7.10.1. Company Overview
    
    7.10.2. Financial Highlights
    
    7.10.3. Product Portfolio
    
    7.10.4. SWOT Analysis
    
    7.10.5. Key Strategies and Developments  7.11. DePuy Synthes Companies (USA)
    

        7.11.1. Company Overview
    
    7.11.2. Financial Highlights
    
    7.11.3. Product Portfolio
    
    7.11.4. SWOT Analysis
    
    7.11.5. Key Strategies and Developments  7.12. Exactech Inc. (USA)
    

        7.12.1. Company Overview
    
    7.12.2. Financial Highlights
    
    7.12.3. Product Portfolio
    
    7.12.4. SWOT Analysis
    
    7.12.5. Key Strategies and Developments  7.13. GS Medical LLC (USA)
    

        7.13.1. Company Overview
    
    7.13.2. Financial Highlights
    
    7.13.3. Product Portfolio
    
    7.13.4. SWOT Analysis
    
    7.13.5. Key Strategies and Developments  7.14. Institut Straumann AG (Switzerland)
    

        7.14.1. Company Overview
    
    7.14.2. Financial Highlights
    
    7.14.3. Product Portfolio
    
    7.14.4. SWOT Analysis
    
    7.14.5. Key Strategies and Developments  7.15. Integra Lifesciences Holdings Corporation (USA)
    

        7.15.1. Company Overview
    
    7.15.2. Financial Highlights
    
    7.15.3. Product Portfolio
    
    7.15.4. SWOT Analysis
    
    7.15.5. Key Strategies and Developments  7.16. Japan Medical Dynamic Marketing Inc. (Japan)
    

        7.16.1. Company Overview
    
    7.16.2. Financial Highlights
    
    7.16.3. Product Portfolio
    
    7.16.4. SWOT Analysis
    
    7.16.5. Key Strategies and Developments  7.17. MED-EL Medical Electronics (Austria)
    

        7.17.1. Company Overview
    
    7.17.2. Financial Highlights
    
    7.17.3. Product Portfolio
    
    7.17.4. SWOT Analysis
    
    7.17.5. Key Strategies and Developments  7.18. Medtronic plc (Ireland)
    

        7.18.1. Company Overview
    
    7.18.2. Financial Highlights
    
    7.18.3. Product Portfolio
    
    7.18.4. SWOT Analysis
    
    7.18.5. Key Strategies and Developments  7.19. Nobel Biocare Services AG (Sweden)
    

        7.19.1. Company Overview
    
    7.19.2. Financial Highlights
    
    7.19.3. Product Portfolio
    
    7.19.4. SWOT Analysis
    
    7.19.5. Key Strategies and Developments  7.20. RTI Surgical#Inc. (USA)
    

        7.20.1. Company Overview
    
    7.20.2. Financial Highlights
    
    7.20.3. Product Portfolio
    
    7.20.4. SWOT Analysis
    
    7.20.5. Key Strategies and Developments  7.21. Showa Ika Kohgyo Co.#Ltd (Japan)
    

        7.21.1. Company Overview
    
    7.21.2. Financial Highlights
    
    7.21.3. Product Portfolio
    
    7.21.4. SWOT Analysis
    
    7.21.5. Key Strategies and Developments  7.22. Smith & Nephew Plc (UK)
    

        7.22.1. Company Overview
    
    7.22.2. Financial Highlights
    
    7.22.3. Product Portfolio
    
    7.22.4. SWOT Analysis
    
    7.22.5. Key Strategies and Developments
    

    8. Assumptions and Acronyms
    
9. Research Methodology
    
10. Contact
  • Inquiry Before Buying

    Inquiry Form

  • Request Sample

    Request for Sample

Related Reports

Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.